Company intelligence / Profile preview

Evexia Life Sciences

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~32
Development stage: Other

Overview

Evexia Life Sciences manufactures and markets region-specific allergy diagnostic kits, custom immunotherapy for allergies, and traditional pharmaceuticals. Their products are FDA approved, GMP-manufactured, and commercialized throughout India, with a focus on improving allergy patient quality of life and reducing reliance on antihistamines and steroids. No clinical trial results are published, as the company focuses on diagnostics and marketed therapies.

Therapeutic areas: ImmunologyPulmonology
Modalities: Diagnostic kitImmunotherapySmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Evexia Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evexia Life Sciences.

Explore the full profile